Development and application of an aggregate adherence metric derived from population pharmacokinetics to inform clinical trial enrichment
Crossref DOI link: https://doi.org/10.1007/s10928-015-9414-4
Published Online: 2015-03-29
Published Print: 2015-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Knights, Jonathan
Rohatagi, Shashank
License valid from 2015-03-29